Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Emerging Therapies Drive Analytical Advancements

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Analyzing Exabytes

Effective analytics will eliminate failures, deviations, and non-conformances.

Company and People Notes: Cherokee and DuPont Form Supply Agreement; Mylan Makes Changes in Management Team; More...

August 06, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Also, Pfizer forms two research agreements in China; NanoInk appoints John Kubricky to its scientific advisory board; more...

EMEA and FDA To Collaborate on Good Clinical Practice

August 06, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

The US Food and Drug Administration and European Medicines Agency (EMEA) launched this week a joint initiative to collaborate on international good clinical practice (GCP) inspection activities.

In the Spotlight August 2009

August 02, 2009

Editors' Picks of Pharmaceutical Science & Technology Innovations

Pharma Capsules

August 02, 2009

Brief pharmaceutical news items for August 2009.

For Biotherapeutics, Innovation is Not Enough

August 02, 2009

Biotech firms must first close the gaps between science and biology on the path toward QbD.

A Dubious Foundation for Quality Control

August 02, 2009

The author of an ambitious book about quality control falls short of reaching his goals.

Comparison of Authentic and Suspect Pharmaceuticals

August 02, 2009

The authors applied near-infrared (NIR) spectrophotometry to assess whether eight drug products were authentic or counterfeit.

Of Hubris and Happy Endings

August 02, 2009

Individuals and companies at the top seem to have no problem short-circuiting their success.

Outsourcing Stability Studies

August 01, 2009

The author provides advice about evaluating contract analytical laboratories and establishing an effective procedure for working with them to perform reliable stability studies.

Personalized Medicine May Lead to More Mergers

July 30, 2009

The number of alliances between diagnostics companies and pharmaceutical companies is set to rise because of the growth of personalized medicine, according to a report from PricewaterhouseCoopers.